AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2021
Jan 5, 2021
31982_dirs_2021-01-05_f8946d50-112e-4bd8-b6b8-b17a53c86d3c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2020-12-31
Reporting Person: DOUGLAS RICHARD (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | Common Stock | M | 1000 | $50.00 | Acquired | 28500 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | Stock Option (Right to Buy) | $50.00 | M | 1000 | Disposed | 2021-03-10 | Common Stock (1000) | Direct |
More from NOVAVAX INC
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Jan 26